Tags

Type your tag names separated by a space and hit enter

Cost-Utility Analysis of Cataract Surgery in Advanced Glaucoma Patients.
J Glaucoma. 2016 07; 25(7):e657-62.JG

Abstract

PURPOSE

To assess the cost-effectiveness of cataract surgery in advanced glaucoma (AG) patients.

MATERIALS AND METHODS

A total of 93 patients with AG who underwent cataract surgeries were collected prospectively from June 2010 through June 2013 in Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai, and were followed up for at least 3 months. A standard phacoemulsification technique was used to remove cataract(s). No complications occurred intraoperatively or postoperatively. Costs associated with surgery were recorded. Utility values of cataract surgery were obtained by using time trade-off method. Quality-adjusted life-years (QALYs) were calculated using the patients' life expectancy at a 3% discounted rate. Incremental cost-utility analysis was performed (compared with no treatment) by calculating the incremental cost-effectiveness ratio (ICER), that is, the mean incremental cost for each QALY. The bootstrap method was used for statistical analysis, and sensitivity analyses were performed to test robustness of the results.

RESULTS

The mean incremental cost of cataract surgery was 9876 Chinese yuan (CNY) [1593 US dollar (USD)] [95% confidence interval (CI), 9144-10,570 CNY (1475-1705 USD)].The mean additional QALYs gained were 2.20 (95% CI, 1.85-2.54), and the incremental cost for each additional QALY was 4508 CNY (727 USD) [95% CI, 3890-5234 CNY (627-844 USD)], far lower than the per capita annual disposable income in Shanghai, 40,188 CNY (6482 USD).

CONCLUSION

For AG patients, cataract surgery does help obtain more QALYs and was highly cost effective.

Authors+Show Affiliations

*Shanghai Eye Hospital, Shanghai Eye Diseases Prevention & Treatment Center †Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

26372156

Citation

Xu, Xian, et al. "Cost-Utility Analysis of Cataract Surgery in Advanced Glaucoma Patients." Journal of Glaucoma, vol. 25, no. 7, 2016, pp. e657-62.
Xu X, Ma YY, Zou HD. Cost-Utility Analysis of Cataract Surgery in Advanced Glaucoma Patients. J Glaucoma. 2016;25(7):e657-62.
Xu, X., Ma, Y. Y., & Zou, H. D. (2016). Cost-Utility Analysis of Cataract Surgery in Advanced Glaucoma Patients. Journal of Glaucoma, 25(7), e657-62. https://doi.org/10.1097/IJG.0000000000000313
Xu X, Ma YY, Zou HD. Cost-Utility Analysis of Cataract Surgery in Advanced Glaucoma Patients. J Glaucoma. 2016;25(7):e657-62. PubMed PMID: 26372156.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cost-Utility Analysis of Cataract Surgery in Advanced Glaucoma Patients. AU - Xu,Xian, AU - Ma,Ying-Yan, AU - Zou,Hai-Dong, PY - 2015/9/16/entrez PY - 2015/9/16/pubmed PY - 2017/11/3/medline SP - e657 EP - 62 JF - Journal of glaucoma JO - J Glaucoma VL - 25 IS - 7 N2 - PURPOSE: To assess the cost-effectiveness of cataract surgery in advanced glaucoma (AG) patients. MATERIALS AND METHODS: A total of 93 patients with AG who underwent cataract surgeries were collected prospectively from June 2010 through June 2013 in Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai, and were followed up for at least 3 months. A standard phacoemulsification technique was used to remove cataract(s). No complications occurred intraoperatively or postoperatively. Costs associated with surgery were recorded. Utility values of cataract surgery were obtained by using time trade-off method. Quality-adjusted life-years (QALYs) were calculated using the patients' life expectancy at a 3% discounted rate. Incremental cost-utility analysis was performed (compared with no treatment) by calculating the incremental cost-effectiveness ratio (ICER), that is, the mean incremental cost for each QALY. The bootstrap method was used for statistical analysis, and sensitivity analyses were performed to test robustness of the results. RESULTS: The mean incremental cost of cataract surgery was 9876 Chinese yuan (CNY) [1593 US dollar (USD)] [95% confidence interval (CI), 9144-10,570 CNY (1475-1705 USD)].The mean additional QALYs gained were 2.20 (95% CI, 1.85-2.54), and the incremental cost for each additional QALY was 4508 CNY (727 USD) [95% CI, 3890-5234 CNY (627-844 USD)], far lower than the per capita annual disposable income in Shanghai, 40,188 CNY (6482 USD). CONCLUSION: For AG patients, cataract surgery does help obtain more QALYs and was highly cost effective. SN - 1536-481X UR - https://www.unboundmedicine.com/medline/citation/26372156/Cost_Utility_Analysis_of_Cataract_Surgery_in_Advanced_Glaucoma_Patients_ L2 - https://doi.org/10.1097/IJG.0000000000000313 DB - PRIME DP - Unbound Medicine ER -